Los Angeles Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
RA
Los Angeles Capital Management's XERS Position: Q2 2026 in Review
Los Angeles Capital Management increased its Xeris Biopharma Holdings (XERS) stake by 1,814% in Q2 2026, buying an estimated $91.6K and bringing the position to 15,141 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1299.
Los Angeles Capital Management first reported a position in XERS in Q2 2025 and has held it in 5 quarters since. The position peaked at $174K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.
- Los Angeles Capital Management held 15,141 shares of Xeris Biopharma Holdings worth $120K as of Q2 2026.
- Los Angeles Capital Management bought 14,350 Xeris Biopharma Holdings shares in Q2 2026, an estimated $91.6K.
- Xeris Biopharma Holdings made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1299 holding.
- Los Angeles Capital Management first reported a position in Xeris Biopharma Holdings in Q2 2025 and has held it in 5 quarters since.
- Los Angeles Capital Management's Xeris Biopharma Holdings position peaked at $174K in Q4 2025.
- 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.